Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
New global care standards to help those living with advanced cancer
In the past, advanced or metastatic cancers were rapidly fatal, however with new treatments people…
New writing therapy helps late-stage cancer patients face biggest fears
Imagine your greatest fear. Now, write it down and tell it in first-person, as if…
World-first microscopic stiffness probe could revolutionise early cancer diagnosis
Researchers at the University of Nottingham, UK, have created an endoscopic device that can 3D…
Benefits of Venetoclax endure years after blood cancer clinical trial
A study which tracked the long-term outcomes of blood cancer patients involved in the MURANO clinical trial has shown enduring…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.